2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Interventions
Specimen Handling
648
pembrolizumab
606
Magnetic Resonance Spectroscopy
559
Carboplatin
446
Cyclophosphamide
394
Cisplatin
394
Biopsy
376
Nivolumab
325
Paclitaxel
324
Gemcitabine
317
Radiotherapy
295
Bevacizumab
245
Dexamethasone
224
fludarabine
214
Docetaxel
202
durvalumab
194
Oxaliplatin
191
venetoclax
187
atezolizumab
179
Fluorouracil
179
Rituximab
174
Capecitabine
170
Pemetrexed
169
Radiation
164
Doxorubicin
164
Radiosurgery
161
Ipilimumab
148
Lenalidomide
143
Leucovorin
139
Etoposide
139
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interferons
×
90 days
×
Clear all
NCT04116502
2026-04-28
MITHRIDATE
University of Birmingham
Phase 3
Recruiting
586 enrolled